Zimmer Biomet (ZBH) news
Recent news
Schouw: Biomer raises FY guidance
Zimmer Biomet Holdings, Inc. has raised its full-year 2026 financial guidance following strong first-quarter performance. The company reported first-quarter net sales of $2.087 billion, reflecting a 9.3% increase compared to the prior year period. On a constant currency basis, sales grew by 6.8%,…
AInvest Wire · Aug 12, 2026Zimmer Biomet Holdings, Inc.: UBS raises target price to $120 from $115
AInvest Wire · Aug 6, 2026Deutsche Bank raises target price for Zimmer Biomet Holdings, Inc. to $98 from $88
AInvest Wire · Aug 6, 2026Zimmer Biomet Holdings, Inc.: Stifel raises target price to $110 from $105
Stifel has raised its price target for Zimmer Biomet Holdings, Inc. (NYSE: ZBH) to $110 from $105, maintaining a Buy rating for the stock. The adjustment follows positive feedback from physician checks on two recently launched products: the Oxford Partial Cementless Knee and Osseofit Stemless…
AInvest Wire · Aug 6, 2026Zimmer Biomet shares up 4.4% after Q2 results beat estimates
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.